Skip to main content
Premium Trial:

Request an Annual Quote

Parent Project Muscular Dystrophy Funds $250K CRISPR Grant for UT-Southwestern

NEW YORK (GenomeWeb) – Parent Project Muscular Dystrophy today announced it has granted $250,000 to University of Texas Southwestern Medical Center researcher Eric Olson for his study of a CRISPR/Cas9-based treatment for Duchenne muscular dystrophy (DMD).

Olson said in a statement that he would use the funding to test the effectiveness and safety of CRISPR in animal models of DMD. The lab will study dystrophin proteins produced using genome editing in mice and compare them to dystrophin produced by other therapeutic approaches, such as gene transfer.

PPMD is a non-profit organization that focused on finding treatments for DMD, a genetic disorder characterized by a lack of dystrophin protein, which is an essential component of muscle and other tissues. The disease affects approximately one in 5,000 males born in the US, PPMD said.

DMD gene therapy has become an early hotspot in CRISPR/Cas9-based gene therapy. In 2014, Olson showed that his lab could prevent DMD phenotype in a mouse model of the disease using the genome editing technology. And in early 2016, he authored one of three papers published simultaneously in Science on fixing DMD in mice.

In 2015, researchers from Toronto's Hospital for Sick Children corrected an exon duplication in cells taken out of a patient with DMD, leading to production of regular dystrophin.

Following these early successes, funding has risen for CRISPR research in DMD. For example, last July, the University of California, Los Angeles received $2.2 million from the California Institute of Regenerative Medicine to evaluate the feasibility of CRISPR DMD gene therapy. 

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.